We value your privacy

This website or its third-party tools process personal data. You can opt out of the sale of your personal information by clicking on the “Do Not Sell or Share My Personal Information” link.

Powered by

Zestril

ACNU Feasibility

View full report
OKZestril (lisinopril) is an oral ACE inhibitor with serious risks like fetal toxicity and angioedema, requiring careful dose adjustments and regular blood and kidney monitoring. It has low misuse potential but complex dosing and notable drug interactions.

ACNU Feasibility Scorecard

Chart with 11 data points.
Zestril
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 8.
End of interactive chart.